Related Experiment Video

Updated: May 27, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
04:40

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

Bee venom in cancer therapy

Nada Oršolić1

  • 1Department of Animal Physiology, University of Zagreb, Zagreb, Croatia. norsolic@yahoo.com

Cancer Metastasis Reviews
|November 24, 2011
PubMed

Insights

Bee venom (BV) shows anti-cancer potential by inducing cell death in various cancer types. Its peptides, like melittin, offer novel therapeutic strategies for tumors.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Bee venom (BV) is traditionally used for immune-related diseases.
  • Recent research explores BV's efficacy in cancer treatment.
  • Key BV components include melittin and phospholipase A2 (PLA2).

Purpose of the Study:

  • To review the anti-cancer properties of bee venom and its compounds.
  • To discuss the molecular mechanisms of BV's cytotoxic and apoptotic effects.
  • To explore novel therapeutic applications of BV in oncology.

Main Methods:

  • Literature review of in vivo and in vitro studies on bee venom and cancer.
  • Analysis of melittin's role in activating cytotoxic pathways (e.g., PLA2, caspases).
  • Investigation of targeted therapy approaches using melittin conjugates and gene therapy.

Main Results:

  • Bee venom demonstrates cytotoxic and antitumor effects against various cancer cells (renal, lung, liver, prostate, breast, leukemia).
  • Melittin induces cancer cell death via apoptosis and activation of specific enzymes.
  • BV exhibits immunomodulatory properties relevant to cancer therapy.

Conclusions:

  • Bee venom, particularly melittin, possesses significant anti-cancer potential.
  • Melittin's mechanisms involve direct cytotoxicity and induction of apoptosis.
  • Targeted delivery systems enhance BV's therapeutic prospects for cancers like prostate and breast cancer.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...